Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
3.
Rev Port Cardiol ; 35(5): 315-6, 2016 May.
Article in English, Portuguese | MEDLINE | ID: mdl-27106730
5.
Int J Cardiovasc Imaging ; 29(7): 1639-44, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23733238

ABSTRACT

It has been advocated that using the stress followed by rest protocol, if the stress images were normal there is no need of rest images, reducing radiation exposure and costs. Our purpose was to assess the prognosis of a group of patients with normal stress-only gated-SPECT myocardial perfusion imaging. This was retrospective study that includes 790 patients with normal myocardial stress only perfusion gated SPECT images. Images were considered as normal if a homogeneous myocardial distribution of the tracer was associated with a normal ejection fraction. The mean follow-up was of 42.8 ± 13.3 months. The considered events were death of all causes, myocardial infarction and myocardial revascularization. During this period there were 85 events (10.8 %), including 57 deaths of all causes (67.1 %), 9 myocardial infarctions (10.6 %), 19 revascularizations (2.4 %). In the first year of follow-up there were 32 events (4.0 %) and excluding non cardiac deaths there were 8 events (1.0 %). Using Cox survival analysis, diabetes (HR = 2.2; CI = 1.4-3.4; p ≤ 0.0005), the history of coronary artery disease (CAD) (HR = 2.1; CI = 1.3-3.2; p ≤ 0.001), age (HR = 1.0; CI = 1.0-1.0; p ≤ 0.05) and type of stress protocol were related with events (exercise test vs. adenosine) (Exercise test: HR = 0.5; CI = 0.3-0.8; p ≤ 0.01). In a multivariate analysis the independent predictors were diabetes, CAD and the type of stress protocol. Based on these results, normal stress-only images are associated with an excellent prognosis even in patients at higher risk, diabetics and patients with known CAD.


Subject(s)
Adenosine , Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography , Coronary Artery Disease/diagnostic imaging , Coronary Circulation , Exercise Test , Myocardial Perfusion Imaging/methods , Vasodilator Agents , Aged , Coronary Artery Disease/complications , Coronary Artery Disease/mortality , Coronary Artery Disease/physiopathology , Coronary Artery Disease/therapy , Electrocardiography , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Multivariate Analysis , Myocardial Infarction/etiology , Myocardial Revascularization , Portugal , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Retrospective Studies , Risk Factors , Stroke Volume , Time Factors
6.
Rev Port Cardiol ; 32(5): 387-94, 2013 May.
Article in English | MEDLINE | ID: mdl-23702241

ABSTRACT

INTRODUCTION: Gated SPECT myocardial perfusion imaging (MPI) has been used to quantify mechanical dyssynchrony. Mechanical dyssynchrony appears to be related to response to cardiac resynchronization therapy. OBJECTIVE: To evaluate the presence and predictors of mechanical dyssynchrony in patients with impaired left ventricular function (LVEF) ≤50%. METHODS: The study included 143 consecutive patients referred for gated SPECT MPI with LVEF ≤50%. Gated SPECT MPI was performed according to a stress/rest protocol acquiring images with Tc 99m-tetrofosmin. Emory Cardiac Toolbox software was used for phase analysis and a standard deviation (SD) ≥43° was considered to indicate mechanical dyssynchrony. RESULTS: Mechanical dyssynchrony was present in 53.1% of the patients. Its predictors were diabetes (OR 2.0, p≤0.05), summed stress score (OR 1.1, p≤0.0005), summed rest score (OR 1.1, p≤0.0001), end-diastolic volume (OR 1.0, p≤0.0001), LVEF (OR 0.9, p≤0.0001), LVEF ≤35% (OR 3.1, p≤0.005) and LVEF ≤35% and QRS ≥120 ms (OR 3.5, p≤0.05). In this study QRS width and QRS ≥120 ms were not predictors of mechanical dyssynchrony. CONCLUSIONS: Myocardial perfusion imaging can be used to assess mechanical dyssynchrony. In patients with impaired ventricular function mechanical dyssynchrony was highly prevalent and was related to parameters of left ventricular function and perfusion.


Subject(s)
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography , Heart Ventricles/physiopathology , Myocardial Perfusion Imaging/methods , Ventricular Dysfunction, Left/complications , Ventricular Dysfunction, Left/diagnostic imaging , Female , Humans , Male , Middle Aged , Retrospective Studies
7.
Rev Port Cardiol ; 28(2): 211-22, 2009 Feb.
Article in English, Portuguese | MEDLINE | ID: mdl-19438156

ABSTRACT

Cardiac myxoma is the most common benign cardiac tumor, and 10% of cases are familial forms. The authors present a review of the literature on the Carney complex, and a case report of a 68-year-old man with a cardiac mass, associated with a significant family history and a diagnosis of coronary embolism.


Subject(s)
Endocrine System Diseases , Heart Neoplasms , Hyperpigmentation , Myxoma , Aged , Endocrine System Diseases/diagnosis , Endocrine System Diseases/genetics , Heart Neoplasms/diagnosis , Heart Neoplasms/genetics , Humans , Hyperpigmentation/diagnosis , Hyperpigmentation/genetics , Male , Myxoma/diagnosis , Myxoma/genetics , Pedigree , Syndrome
8.
Rev Port Cardiol ; 27(4): 531-44, 2008 Apr.
Article in English, Portuguese | MEDLINE | ID: mdl-18605071

ABSTRACT

The management of patients taking long-term oral anticoagulants who require dental surgery is still highly controversial. The risk of bleeding associated with dental treatment under oral anticoagulants must be weighed against the risk of thromboembolism associated with suspension of antithrombotic therapy. Mortality and morbidity associated with thromboembolic events are higher than those associated with hemorrhagic events after minor oral surgery procedures. Evidence-based information does not support oral anticoagulant suspension before minor oral surgery. The authors propose a management protocol for chronically anticoagulated patients who require a dental procedure, to reduce both thromboembolic risk and the risk of bleeding.


Subject(s)
Anticoagulants/administration & dosage , Oral Surgical Procedures , Anticoagulants/adverse effects , Clinical Protocols , Humans , Risk Factors , Warfarin/administration & dosage , Warfarin/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...